Target
Mu-type opioid receptor
Ligand
BDBM464631
Substrate
n/a
Meas. Tech.
Receptor Binding Assay
Ki
2910±n/a nM
Citation
 Kuehnert, SKoenigs, RMKless, AWegert, ARatcliffe, PJostock, RKoch, TLinz, KSchroeder, W 8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives US Patent  US10793556 Publication Date 10/6/2020 
Target
Name:
Mu-type opioid receptor
Synonyms:
M-OR-1 | MOP | MOR-1 | MOR1 | MUOR1 | Mu Opioid Receptor | Mu opiate receptor | OPIATE Mu | OPRM1 | OPRM_HUMAN | hMOP | mu-type opioid receptor isoform MOR-1
Type:
G Protein-Coupled Receptor (GPCR)
Mol. Mass.:
44789.51
Organism:
Homo sapiens (Human)
Description:
P35372
Residue:
400
Sequence:
MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP
  
Inhibitor
Name:
BDBM464631
Synonyms:
CIS-3-(1-Benzoyl-piperidin-4-yl)-8-dimethylamino-8-phenyl-1,3- diazaspiro[4.5]decan-2-one | US10793556, Example SC_4059 | US10793556, Example SC_4060 | US10793556, Example SC_4061 | US10793556, Example SC_4062 | US10793556, Example SC_4063 | US10793556, Example SC_4064
Type:
Small organic molecule
Emp. Form.:
C26H39N3O4S
Mol. Mass.:
489.671
SMILES:
CN(C)[C@]1(CC[C@]2(CN(CC3(O)CCS(=O)(=O)CC3)C(=O)N2CC2CC2)CC1)c1ccccc1 |r,wU:6.22,3.2,(5.79,-5.96,;4.31,-5.56,;3.91,-4.08,;3.22,-6.65,;2.45,-7.99,;.91,-7.99,;.14,-6.65,;-.77,-5.41,;-2.23,-5.88,;-3.48,-4.98,;-4.88,-5.61,;-4.69,-3.95,;-6.13,-4.7,;-7.54,-5.33,;-7.7,-6.86,;-8.79,-7.95,;-9.19,-6.46,;-6.45,-7.76,;-5.05,-7.14,;-2.23,-7.42,;-3.48,-8.33,;-.77,-7.9,;-.29,-9.36,;-1.32,-10.51,;-2.79,-10.98,;-1.64,-12.02,;.91,-5.32,;2.45,-5.32,;4.31,-7.74,;3.91,-9.23,;5,-10.32,;6.49,-9.92,;6.88,-8.43,;5.79,-7.34,)|
Structure:
Search PDB for entries with ligand similarity: